
Photon Biosciences, LLC develops a next-generation diagnostic platform called PBSDx that integrates advanced biological imaging molecules, AI/machine learning algorithms, and optical technologies to deliver portable, faster, and more accurate diagnostic testing than traditional laboratory methods. Their platform supports a portfolio of human and veterinary diagnostic tests, including heart failure multiplex testing, bacterial contamination detection in blood platelets, and companion animal diagnostics. The company collaborates with commercial, academic, and government partners to expand its test offerings, aiming to enable accessible, on-the-go health decision-making for humans and animals.

Photon Biosciences, LLC develops a next-generation diagnostic platform called PBSDx that integrates advanced biological imaging molecules, AI/machine learning algorithms, and optical technologies to deliver portable, faster, and more accurate diagnostic testing than traditional laboratory methods. Their platform supports a portfolio of human and veterinary diagnostic tests, including heart failure multiplex testing, bacterial contamination detection in blood platelets, and companion animal diagnostics. The company collaborates with commercial, academic, and government partners to expand its test offerings, aiming to enable accessible, on-the-go health decision-making for humans and animals.